| Basics |
|
Innovus Pharmaceuticals Inc
|
| IPO Date: |
March 4, 2021 |
| Sector: |
Healthcare |
| Industry: |
Medical Care Facilities |
| Market Cap: |
$682.48M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.21 | 3.16%
|
| Avg Daily Range (30 D): |
$0.27 | 5.31%
|
| Avg Daily Range (90 D): |
$0.20 | 4.35%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.14M |
| Avg Daily Volume (30 D): |
.16M |
| Avg Daily Volume (90 D): |
.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
100 |
| Avg Trade Size (Sh.) (30 D): |
73 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Inst.Trades: |
117 |
| Avg Inst. Trade: |
$2.6M |
| Avg Inst. Trade (30 D): |
$.67M |
| Avg Inst. Trade (90 D): |
$.67M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.86M |
| Avg Closing Trade (30 D): |
$.67M |
| Avg Closing Trade (90 D): |
$.67M |
| Avg Closing Volume: |
246.33K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.12
|
$.06
|
$
|
|
Diluted EPS
|
$-.12
|
$.06
|
$
|
|
Revenue
|
$ 884.66M
|
$ 236.11M
|
$ 221.42M
|
|
Gross Profit
|
$ 170.45M
|
$ 51.36M
|
$ 41.29M
|
|
Net Income / Loss
|
$ -21.96M
|
$ 7.67M
|
$ -5.01M
|
|
Operating Income / Loss
|
$ -16.58M
|
$ 8.29M
|
$ -2.15M
|
|
Cost of Revenue
|
$ 281.41M
|
$ 75.89M
|
$ 71.96M
|
|
Net Cash Flow
|
$ 29.26M
|
$ 3.1M
|
$ 4.73M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Mar 18, 2019:
1:105
|
|
|
|